HC
DXCM icon

HNP Capital’s DexCom DXCM Stock Holding History

HNP Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1.62M Sell
13,901
-436
-3% -$48.8K 0.45% 57
2022
Q4 		$1.62M Sell
14,337
-1,880
-12% -$206K 0.45% 58
2022
Q3 		$1.31M Sell
16,217
-129
-0.8% -$10.9K 0.38% 66
2022
Q2 		$1.22M Sell
16,346
-186
-1% -$17K 0.34% 73
2022
Q1 		$2.11M Buy
16,532
+592
+4% +$64.8K 0.5% 49
2021
Q4 		$2.14M Buy
15,940
+360
+2% +$51.7K 0.48% 53
2021
Q3 		$2.13M Buy
15,580
+488
+3% +$61.5K 0.53% 49
2021
Q2 		$1.61M Buy
15,092
+756
+5% +$72.6K 0.43% 54
2021
Q1 		$1.29M Buy
14,336
+1,436
+11% +$135K 0.38% 64
2020
Q4 		$1.19M Buy
12,900
+1,576
+14% +$141K 0.39% 63
2020
Q3 		$1.02M Buy
11,324
+3,452
+44% +$361K 0.37% 67
2020
Q2 		$802K Buy
+7,872
New +$704K 0.33% 66

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HNP Capital's DXCM Position: Q1 2023 in Review

HNP Capital reduced its DexCom (DXCM) stake by 3% in Q1 2023, selling an estimated $48.8K and leaving 13,901 shares worth $1.62M. The position accounts for 0.45% of the portfolio, ranked #57.

HNP Capital first reported a position in DXCM in Q2 2020 and has held it in 12 quarters since. The position peaked at $2.14M in Q4 2021. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • HNP Capital held 13,901 shares of DexCom worth $1.62M as of Q1 2023.
  • HNP Capital sold 436 DexCom shares in Q1 2023, an estimated $48.8K.
  • DexCom made up 0.45% of HNP Capital's portfolio in Q1 2023, its #57 holding.
  • HNP Capital first reported a position in DexCom in Q2 2020 and has held it in 12 quarters since.
  • HNP Capital's DexCom position peaked at $2.14M in Q4 2021.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.